Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Role of gonadal hormones on mu-opioid-stimulated [³⁵S]GTPγS binding and morphine-mediated antinociception in male and female Sprague-Dawley rats.

Peckham EM, Graves SM, Jutkiewicz E, Becker JB, Traynor JR.

Psychopharmacology (Berl). 2011 Dec;218(3):483-92. doi: 10.1007/s00213-011-2335-z. Epub 2011 May 24.

PMID:
21607564
2.

Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G.

Wang YJ, Huang P, Blendy JA, Liu-Chen LY.

Addict Biol. 2014 May;19(3):354-61. doi: 10.1111/j.1369-1600.2012.00484.x. Epub 2012 Aug 2.

3.

[(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.

Madia PA, Navani DM, Yoburn BC.

Pharmacol Biochem Behav. 2012 Mar;101(1):155-65. doi: 10.1016/j.pbb.2011.11.001. Epub 2011 Nov 12.

PMID:
22108651
5.

Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.

Maher CE, Selley DE, Childers SR.

Biochem Pharmacol. 2000 Jun 1;59(11):1395-401.

PMID:
10751548
6.

Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.

Smith PA, Selley DE, Sim-Selley LJ, Welch SP.

Eur J Pharmacol. 2007 Oct 1;571(2-3):129-37. Epub 2007 Jun 12.

7.
9.
10.

Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.

Ohsawa M, Mizoguchi H, Narita M, Kamei J, Nagase H, Tseng LF.

Eur J Pharmacol. 2000 Jul 28;401(1):55-8.

PMID:
10915837
11.

Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.

Peckham EM, Traynor JR.

J Pharmacol Exp Ther. 2006 Mar;316(3):1195-201. Epub 2005 Nov 16.

12.

Mu opioid receptor signaling in morphine sensitization.

Viganò D, Rubino T, Di Chiara G, Ascari I, Massi P, Parolaro D.

Neuroscience. 2003;117(4):921-9.

PMID:
12654343
13.

Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain.

Selley DE, Herbert JT, Morgan D, Cook CD, Picker MJ, Sim-Selley LJ.

Brain Res Bull. 2003 May 15;60(3):201-8.

PMID:
12754081
14.

Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.

Peckham EM, Barkley LM, Divin MF, Cicero TJ, Traynor JR.

Brain Res. 2005 Oct 5;1058(1-2):137-47. Epub 2005 Sep 1.

PMID:
16139823
15.

Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.

Maher CE, Martin TJ, Childers SR.

Life Sci. 2005 Jul 22;77(10):1140-54.

PMID:
15890372
16.

The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.

Xie H, Woods JH, Traynor JR, Ko MC.

Anesth Analg. 2008 Jun;106(6):1873-81. doi: 10.1213/ane.0b013e31817300be.

17.

Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the mu-opioid receptor.

Heinzen EL, Booth RG, Pollack GM.

Biochem Pharmacol. 2005 Feb 15;69(4):679-88. Epub 2005 Jan 7.

PMID:
15670586
19.
20.

Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.

Kirschke C, Schadrack J, Zieglgänsberger W, Spanagel R.

Eur J Pharmacol. 2002 Jun 20;446(1-3):43-51.

PMID:
12098584

Supplemental Content

Support Center